NNNN · Anbio Biotechnology
Market Cap
$316.89M
Shares
43.89M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.22
Open$7.32
Day$6.76–7.40
52W close$6.81–47.85
Avg vol 30d143K
Short int26K · 0.1% float · 1.0d
Short vol63%
DataFeb 2025–Sep 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−68%
below
Price vs 50-day avg
−29%
below
RSI (14)
34
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−29%
trailing
6-month return
−67%
trailing
YTD return
−76%
this year
Relative strength
−80%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $23 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -44.9% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
12 holders — near 1-yr high, broad support
Squeeze score
24
low risk · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
87%
expanding
EPS growth
+163%
Y/Y
Quant / Vol
risk profile
Volatility
143%
annualized · 1-yr
Max drawdown
−86%
past year
ATR
18.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−68%
Bearish
Price vs 50-day avg
−29%
Bearish
RSI (14)
34
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $10 › 200d $23 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -44.9% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
12 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $7
Now $7 · 1%
Range high $48
vs 200-day avg -68%
vs 50-day avg -29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NNNN
this stock
Anbio Biotechnology
|
$316.89M | -76.0% | +5.6% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$130.45B | -34.8% | +20.5% | 42.4 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$51.24B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$46.16B | -16.4% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$34.83B | -9.0% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NNNN | -7.8% | -28.9% | -67.1% | -1.1% | -76.0% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -7.3% | -27.6% | -79.7% | -0.4% | -87.7% |
Key facts
CIK
1982708
CUSIP
G0367B105
13F (30d)
10 filings
10 filers
Visit website
Investor relations